Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection

NCT02363322 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

NIH

Sponsor class

Conditions

Ebola Virus Infection

Interventions

DRUG: B/Current Standard of Care Plus ZMapp
OTHER: A/Current Standard of Care Alone

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]